Skip to product information
 (1013 Reviews)

Ourlyard™ Ruxolitinib Cream 1.5%

Ourlyard™ Ruxolitinib Cream 1.5%

⏰ 90 Days Money-Back Guarantee

✅ FDA & SGS Approved

✅ Made in USA 🇺🇸

✅ Worldwide Express Shipping

✅ Suitable for All Ages, All Races, All Genders

Regular price $24.97
Regular price $24.97 Sale price
SAVE Sold out
 

BUNDLE & SAVE

Shipping Insurance

Shipping Insurance

Protect your shipment from damage, loss or theft.

Pay with
Ourlyard™ Ruxolitinib Cream 1.5%

Ourlyard™ Ruxolitinib Cream 1.5%

Regular price $24.97
Regular price $24.97 Sale price
SAVE Sold out

Uses:

- Nonsegmental vitiligo 

- Mild to moderate atopic dermatitis 

- Improves skin pigmentation in vitiligo and reduces inflammation in atopic dermatitis.

- Helps restore color to affected areas and alleviates symptoms such as itching and redness. 

- Decreases the need for other treatments by effectively managing these conditions.

Safety Information

- Ourlyard™ is for use on the skin only. 

- Do not use Ourlyard™ in your eyes, mouth, or vagina.

Description

Ourlyard™  contains ruxolitinib, a selective Janus kinase (JAK) inhibitor. This topical cream is designed for the treatment of specific dermatological conditions such as nonsegmental vitiligo and mild to moderate atopic dermatitis. Each batch of Ourlyard™  is carefully formulated to ensure consistency and efficacy. Ruxolitinib works by modulating the body's immune response, reducing inflammation, and promoting skin repigmentation. It is particularly effective for patients who do not respond well to other topical therapies or where those therapies are not advisable. Key ingredients: Ruxolitinib: A potent JAK1/JAK2 inhibitor, it plays a crucial role in managing inflammatory responses and aiding in skin pigmentation restoration. Emollients: To provide moisture and improve skin texture. Stabilizers: Ensuring the consistency and stability of the cream for effective application. 

Why Choose Ourlyard™

Ourlyard™ is specifically formulated for targeted treatment of atopic dermatitis and vitiligo, providing relief from symptoms such as itching, redness, and skin depigmentation. Its unique mechanism of action allows for effective management of these conditions with fewer side effects compared to systemic treatments. Topical application of Ourlyard™ allows for direct action on affected areas, offering rapid relief and improvement in skin condition. This precision treatment minimizes the risk of systemic side effects commonly associated with oral JAK inhibitors. Choose Ourlyard™ for a scientifically backed, clinically proven solution to managing challenging dermatological conditions with the convenience and targeted action of a topical cream. 

RELIEF YOU CAN FEEL

Ourlyard™ is a prescription medicine used on the skin (topical) for:

  • short-term and non-continuous chronic treatment of mild to moderate eczema (atopic dermatitis) in non-immunocompromised adults and children 12 years of age and older whose disease is not well controlled with topical prescription therapies or when those therapies are not recommended

The use of Ourlyard™ along with therapeutic biologics, other JAK inhibitors, or strong immunosuppressants such as azathioprine or cyclosporine is not recommended.

Usage

Ourlyard™ is a prescription medicine used on the skin (topical) for:

  • short-term and non-continuous chronic treatment of mild to moderate eczema (atopic dermatitis) in non-immunocompromised adults and children 12 years of age and older whose disease is not well controlled with topical prescription therapies or when those therapies are not recommended
  • the treatment of a type of vitiligo called nonsegmental vitiligo in adults and children 12 years of age and older

The use of Ourlyard™ along with therapeutic biologics, other JAK inhibitors, or strong immunosuppressants such as azathioprine or cyclosporine is not recommended.

 

 

View full details